Retatrutide

About this Compound

Retatrutide is a novel investigational peptide being studied for its effects on weight management and metabolic health. It is a 'triple agonist,' activating three receptors involved in energy balance and metabolism: GLP-1, GIP, and glucagon.

Research Highlights

• Research trials report substantial and sustained decreases in body weight
• Unlike semaglutide or tirzepatide, also activates the glucagon receptor
• Early data indicate potential improvements in insulin sensitivity and glucose control
• Studied for possible benefits in reducing liver fat